“For more than a decade, the team at SafePassage has been dedicated to serving patients and surgeons with premium quality intraoperative neurophysiological monitoring services to improve patient outcomes and reduce economic risk for hospitals and surgeons. We are extremely passionate about our vision to help eradicate preventable healthcare injury, the third leading cause of death in the United States, and I look forward to joining forces with NuVasive to further our mission worldwide.” Dan Siegel, CEO of SafePassage
Learn more at NuVasive.com
Balancing Quality of Patient Care with Quality of Life for our care providers
Safe Passage is one of the fastest-growing IONM companies in the nation, with nearly 100 team members serving over 150 surgeons and thousands of patients each year. Despite the consistent growth, we remain committed to our values. We established regional teams to maintain consistency for our surgeons, maximize continuity of care for our patients, and minimize travel for our employees. Here at Safe Passage, everyone is family. From our neurophysiologists to our office and medical staff, we all feel a sense of camaraderie and support. We are among the fastest-growing IONM companies nation-wide because our top priorities are patient safety, surgeon satisfaction and quality of life for our employees
Investing In The Next Generation of Neurophysiologists
As leaders in IONM education, we invest in the next generation of neurophysiologists by partnering with academic institutions to develop degree programs in IONM. Members of our clinical leadership team develop IONM-specific curricula, and even serve as adjunct faculty members to ensure that students receive their IONM education from experts who actually work in the field. Outside of the classroom, we combine our education platform with an emphasis on medical mission trips, as well as funding local charities.
Clinicians from the Board Room to the Operating Room
As surgeons who have relied on neuromonitoring for over 30 years, our founders, Dr. Seth Neubardt and Dr. Jack Stern became concerned that many IONM companies were being run by investors and not clinicians. They saw the quality of neuromonitoring suffer as many companies prioritized their financial bottom line over the quality of patient care. So what did they do about it? They founded Safe Passage Neuromonitoring, where clinical decisions are made by clinically-trained experts. We don’t answer to outside investors, and we live by the principle of patient safety above all else.